We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+20.91%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$173M
AUM Growth
+$20M
Cap. Flow
-$415K
Cap. Flow %
-0.24%
Top 10 Hldgs %
35.73%
Holding
114
New
14
Increased
30
Reduced
33
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 63.04%
2 Technology 16.06%
3 Communication Services 5.94%
4 Industrials 4.11%
5 Consumer Staples 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
26
Castle Biosciences
CSTL
$953M
$2.29M 1.33%
33,500
-1,000
-3% -$75.2K
ATRS
27
DELISTED
Antares Pharma, Inc.
ATRS
$2.23M 1.29%
542,283
+61,500
+13% +$267K
CSLT
28
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.2M 1.27%
1,459,500
+255,500
+21% +$443K
CSII
29
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.95M 1.13%
50,767
-990
-2% -$42.1K
ELUT icon
30
Elutia
ELUT
$38.5M
$1.92M 1.11%
138,925
-450
-0.3% -$6.73K
BIOR
31
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$1.92M 1.11%
1,614
-40
-2% -$55.1K
OOMA icon
32
Ooma
OOMA
$592M
$1.9M 1.1%
119,800
+64,450
+116% +$1M
VG
33
DELISTED
Vonage Holdings Corporation
VG
$1.84M 1.07%
156,025
PFIE
34
DELISTED
Profire Energy, Inc
PFIE
$1.79M 1.04%
1,628,880
-225,109
-12% -$259K
SHSP
35
DELISTED
SharpSpring, Inc.
SHSP
$1.79M 1.03%
111,825
+6,500
+6% +$129K
PFE icon
36
Pfizer
PFE
$145B
$1.77M 1.03%
48,928
-620
-1% -$22K
ZIXI
37
DELISTED
Zix Corporation
ZIXI
$1.76M 1.02%
232,675
+179,175
+335% +$1.51M
QUIK icon
38
QuickLogic
QUIK
$260M
$1.62M 0.94%
233,785
-11,817
-5% -$70.8K
TGT icon
39
Target
TGT
$67.3B
$1.55M 0.9%
7,829
-250
-3% -$46.8K
CATX icon
40
Perspective Therapeutics
CATX
$342M
$1.52M 0.88%
139,900
+89,900
+180% +$1.36M
SONM icon
41
DNA X Inc
SONM
$6.07M
$1.49M 0.86%
1,011
+653
+182% +$1.15M
RYM
42
RYTHM Inc
RYM
$55.4M
$1.41M 0.82%
+38
New +$1.57M
INTZ
43
DELISTED
INTRUSION INC NEW
INTZ
$1.4M 0.81%
59,750
-750
-1% -$17.5K
BIOL
44
DELISTED
Biolase, Inc.
BIOL
$1.4M 0.81%
662
+175
+36% +$430K
XLNX
45
DELISTED
Xilinx Inc
XLNX
$1.34M 0.77%
+10,795
New +$1.44M
ABBV icon
46
AbbVie
ABBV
$431B
$1.33M 0.77%
12,313
+125
+1% +$13.4K
PERI icon
47
Perion Network
PERI
$386M
$1.32M 0.77%
+74,000
New +$1.34M
MMM icon
48
3M
MMM
$93.6B
$1.26M 0.73%
7,841
T icon
49
AT&T
T
$160B
$1.23M 0.71%
53,823
+758
+1% +$16.8K
BMY icon
50
Bristol-Myers Squibb
BMY
$135B
$1.04M 0.6%
16,450

Similar funds

Perkins Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Perkins Capital Management held 114 positions worth $173M, up 13% from $153M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Perkins Capital Management's Q1 2021 filing shows 14 new, 30 increased, 33 reduced and 8 closed positions. Its largest new stake was Chembio diagnostics, Inc.: 289,680 shares worth $1.02M. The largest sale was Magnite, an estimated $7.28M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 64% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q1 2021 buy was Chembio diagnostics, Inc.: 289,680 shares worth $1.02M.
  • Perkins Capital Management added most to Streamline Health Solutions in Q1 2021, an estimated $2.62M increase.
  • Perkins Capital Management's biggest Q1 2021 reduction was Magnite, cutting an estimated $7.28M.
  • Perkins Capital Management fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $2.35M.
  • Perkins Capital Management's ten largest holdings make up 36% of its $173M portfolio in Q1 2021.
  • Perkins Capital Management opened 14 new positions and closed 8 in Q1 2021.
  • Perkins Capital Management's portfolio value rose 13% quarter-over-quarter to $173M.

Based on Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.